Cabungcag, Zhellian .

HRN: 21-73-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2022
08/14/2022
IV
105 Mg
Q8H
AMOEBIASIS
Waiting Final Action 
08/07/2022
AMPICILLIN 1GM (VIAL)
08/07/2022
08/14/2022
IV
263mg
Q6H
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: